Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 27, 2023

BUY
$1.61 - $2.54 $420,092 - $662,754
260,927 Added 100.0%
521,854 $944,000
Q2 2022

Aug 04, 2022

SELL
$2.2 - $4.2 $643,676 - $1.23 Million
-292,580 Reduced 52.86%
260,927 $621,000
Q1 2022

May 10, 2022

BUY
$2.83 - $8.69 $735,528 - $2.26 Million
259,904 Added 88.52%
553,507 $2.23 Million
Q4 2021

Feb 10, 2022

BUY
$8.31 - $14.92 $1.69 Million - $3.04 Million
203,903 Added 227.32%
293,603 $2.44 Million
Q3 2021

Nov 09, 2021

BUY
$9.15 - $13.28 $820,755 - $1.19 Million
89,700 New
89,700 $1.04 Million

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $12.1B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.